Neuroleptic Malignant Syndrome

Neuroleptic malignant syndrome, characterized by fever, muscular rigidity, and dysautonomia, occurs with exposure to dopamine-blocking agents. Management, especially in critical care contexts, is described.

​   The New England Journal of Medicine: Search Results in Pulmonary/Critical Care